Scout | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is offering funding for R01 research projects that use advanced cancer biology techniques to investigate how different types of radiation in radionuclide-based therapies, like radiopharmaceutical therapy, affect normal tissue, tumor cells, and the surrounding tumor environment.

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Dates

Opportunity Released: November 18, 2024

Submission Deadline: May 7, 2025

Application Window Closes: May 7, 2025

Open for Submission: November 18, 2024

Keywords

Cancer

Radionuclide Therapy

Radiopharmaceutical

Tumor Microenvironment

Radiation Effects

Normal Tissue

Cancer Biology

Research Projects

Therapeutics

National Cancer Institute

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers